Anavex®Life Sciences Issued New U.S. Patent for Composition of Matter Covering ANAVEX®2-73

NEW YORK – September 5, 2017 – Anavex® Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL) today announced that the United States Patent and Trademark Office has issued U.S. Patent Number 9,750,746 entitled “ANAVEX® 2-73 and certain anticholinesterase inhibitors composition and method for neuroprotection.”  This patent provides the Company with intellectual property protection covering…